|
| 9:00 - 9:30 | Welcome and coffee |
| 9:30 - 10:10 | GM-CSF: from growth factor to master regulator of tissue inflammation - Burkhard Becher |
| 10:10 - 10:20 | The Rac–Pak signaling axis controls Inflammasome activation during psoriasis - Ludovic Batistic |
| 10:20 - 10:30 | Targeting lipid-associated macrophages to overcome immunosuppression in brain metastasis - Bastien Dolfi |
| 10:30 - 10:30 | Coffee break |
| 11:00 - 11:40 | To be announced - Alexander Mildner |
| 11:40 - 12:20 | Untangling monocyte differentiation pathways and mononuclear phagocyte diversity. - Alexandre Gallerand |
| 12:20 - 13:30 | Lunch |
| 13:30 - 14:10 | Defining the Niche: Myeloid and Stromal Synergy in the Testis. - Marc Bajénoff |
| 14:10 - 14:20 | Generation, localization and functions of macrophages during the development of testis - Laura Lintukorpi |
| 14:20 - 14:30 | Dynamics in Osteoclasts: A Single-Cell Perspective on Fusion and Fission - Valeriia Rezapova |
| 14:30 - 15:00 | Coffee break |
| 15:00 - 15:40 | Rethinking inflammation: insights from pancreatic islet-resident macrophages - Elise Dalmas |
| 15:40 - 16:20 | Brain border myeloid cells: more than immune sentinels? - Rejane Rua |
| 16:20 - 16:30 | Immunological effects of FLT3 inhibitors in the post-transplant period in Acute Myeloid Leukemia - Chloé Delaby |
| 16:30 - 16:40 | MHCII-TIMD4+ tissue resident bone marrow macrophages control myelopoiesis - Yohan GERBER-FERDER |
| 16:40 - 17:00 | Concluding remarks - Concluding remarks |
| 9:00 - 9:30 | Welcome and coffee |
| 9:30 - 10:10 | Immunomodulatory mechanisms of Itaconate - Maxim Artyomov |
| 10:10 - 10:20 | PVR and Nectin-2 blockade trigger macrophage anti-tumor functions, promote immune cell recruitment and prevent - Laurent Gorvel |
| 10:20 - 10:30 | Embryonic macrophages shape brown adipose tissue development and early-life thermogenesis - Janni Ollikainen |
| 10:30 - 11:00 | Coffee break |
| 11:00 - 11:40 | To be announced - Olivier Thaunat |
| 11:40 - 12:20 | Unveiling the active role of macrophages in the pituitary gland. - Pia Rantakari |
| 12:20 - 12:40 | Concluding remarks |
|
|